BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 24565680)

  • 21. Sentinel lymph node biopsy alone has no adverse impact on the survival of patients with breast cancer.
    Takei H; Suemasu K; Kurosumi M; Horii Y; Ninomiya J; Yoshida M; Hagiwara Y; Inoue K; Tabei T
    Breast J; 2006; 12(5 Suppl 2):S157-64. PubMed ID: 16958996
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Internal mammary nodal chain drainage is a prognostic indicator in axillary node-positive breast cancer.
    Yao MS; Kurland BF; Smith AH; Schubert EK; Dunnwald LK; Byrd DR; Mankoff DA
    Ann Surg Oncol; 2007 Oct; 14(10):2985-93. PubMed ID: 17564747
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lymph node ratio as an alternative to pN staging for predicting prognosis after neoadjuvant chemotherapy in breast cancer.
    Cho DH; Bae SY; You JY; Kim HK; Chang YW; Choi YJ; Woo SU; Son GS; Lee JB; Bae JW; Jung SP
    Kaohsiung J Med Sci; 2018 Jun; 34(6):341-347. PubMed ID: 29747778
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Additional Prognostic Value of Lymph Node Ratio (LNR) and Number of Negative Lymph Nodes (NLNs) in Chinese Patients with Triple Negative Breast Cancer.
    Wang QX; Cai YF; Chen YY; Zhang W; Jin WX; Chen ED; Zhang XH; Li Q
    Ann Clin Lab Sci; 2017 Jan; 47(1):68-75. PubMed ID: 28249920
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic Value of Lymph Node Ratio in Breast Cancer Patients with Adequate Pathologic Evidence After Neoadjuvant Chemotherapy.
    Ai X; Liao X; Wang M; Hu Y; Li J; Zhang Y; Tang P; Jiang J
    Med Sci Monit; 2020 Apr; 26():e922420. PubMed ID: 32348295
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lymph node ratio as an alternative to pN staging in node-positive breast cancer.
    Vinh-Hung V; Verkooijen HM; Fioretta G; Neyroud-Caspar I; Rapiti E; Vlastos G; Deglise C; Usel M; Lutz JM; Bouchardy C
    J Clin Oncol; 2009 Mar; 27(7):1062-8. PubMed ID: 19164210
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic value of metastatic axillary lymph node ratio for Chinese breast cancer patients.
    Wu SG; He ZY; Li Q; Sun JY; Li FY; Lin Q; Lin HX; Guan XX
    PLoS One; 2013; 8(4):e61410. PubMed ID: 23626682
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Micrometastatic breast cancer cells in bone marrow at primary surgery: prognostic value in comparison with nodal status.
    Diel IJ; Kaufmann M; Costa SD; Holle R; von Minckwitz G; Solomayer EF; Kaul S; Bastert G
    J Natl Cancer Inst; 1996 Nov; 88(22):1652-8. PubMed ID: 8931609
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic value of axillary lymph node metastases in invasive lobular breast carcinoma.
    Deberti M; Goupille C; Arbion F; Vilde A; Body G; Ouldamer L
    J Gynecol Obstet Hum Reprod; 2023 Dec; 52(10):102665. PubMed ID: 37734568
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Micrometastatic node-positive breast cancer: long-term outcomes and identification of high-risk subsets in a large population-based series.
    Truong PT; Lesperance M; Li KH; MacFarlane R; Speers CH; Chia S
    Ann Surg Oncol; 2010 Aug; 17(8):2138-46. PubMed ID: 20151215
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The lymph node ratio as an independent prognostic factor for node-positive triple-negative breast cancer.
    He M; Zhang JX; Jiang YZ; Chen YL; Yang HY; Tang LC; Shao ZM; Di GH
    Oncotarget; 2017 Jul; 8(27):44870-44880. PubMed ID: 28496004
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Patients with recurrent breast cancer: does the primary axillary lymph node status predict more aggressive tumor progression?
    Rack B; Janni W; Gerber B; Strobl B; Schindlbeck C; Klanner E; Rammel G; Sommer H; Dimpfl T; Friese K
    Breast Cancer Res Treat; 2003 Nov; 82(2):83-92. PubMed ID: 14692652
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Percent positive axillary lymph node metastasis predicts survival in patients with non-metastatic breast cancer.
    Lale Atahan I; Yildiz F; Ozyigit G; Sari S; Gurkaynak M; Selek U; Hayran M
    Acta Oncol; 2008; 47(2):232-8. PubMed ID: 17924207
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Eight-year follow up result of the OTOASOR trial: The Optimal Treatment Of the Axilla - Surgery Or Radiotherapy after positive sentinel lymph node biopsy in early-stage breast cancer: A randomized, single centre, phase III, non-inferiority trial.
    Sávolt Á; Péley G; Polgár C; Udvarhelyi N; Rubovszky G; Kovács E; Győrffy B; Kásler M; Mátrai Z
    Eur J Surg Oncol; 2017 Apr; 43(4):672-679. PubMed ID: 28139362
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Development and validation of a nomogram for predicting survival on the base of modified lymph node ratio in breast cancer patients.
    Wen J; Yang Y; Liu P; Ye F; Tang H; Huang X; Zhong S; Xie X
    Breast; 2017 Jun; 33():14-22. PubMed ID: 28259045
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lymph node ratio and pN staging show different superiority as prognostic predictors depending on the number of lymph nodes dissected in Chinese patients with luminal A breast cancer.
    Wang F; He W; Qiu H; Wang X; Guo G; Chen X; Rong Y; Zhou F; Yin C; Yuan Z; Xia L
    Clin Breast Cancer; 2012 Dec; 12(6):404-11. PubMed ID: 23026023
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Does the metastatic lymph node ratio influence the disease-free survival of patients with breast cancer: single-center experiences.
    Oven Ustaalioglu BB; Bilici A; Kefeli U; Seker M; Yildirim E; Salepci T; Oncel M; Kement M; Gumus M
    Oncology; 2010; 79(1-2):105-11. PubMed ID: 21088436
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognosis of breast cancer: evidence for interaction between c-erbB-2 overexpression and number of involved axillary lymph nodes.
    Mittra I; Redkar AA; Badwe RA
    J Surg Oncol; 1995 Oct; 60(2):106-11. PubMed ID: 7564375
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The prognostic significance of the lymph node ratio in axillary lymph node positive breast cancer.
    Kim JY; Ryu MR; Choi BO; Park WC; Oh SJ; Won JM; Chung SM
    J Breast Cancer; 2011 Sep; 14(3):204-12. PubMed ID: 22031802
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Better predictive value of axillary lymph node (ALN) status after systemic therapy for operable HER2-overexpressing breast cancer: A single-institution retrospective study.
    Zhang Y; Mo M; Li JW; Zhou Y; Wu J; Yu KD; Shen ZZ; Shao ZM; Liu GY
    Eur J Surg Oncol; 2016 Aug; 42(8):1146-52. PubMed ID: 27365197
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.